Don's Clinical Trial

Here is the clinical trial Don is participating in. He is #5 of 100 subjects in the protocol. He is participating in the NY-ESO-1 arm of the study.
Clinical Trial: Study of MAGE-A3 and NY-ESO-1 Immunotherapy in Combo With DTPACE Chemo and Auto Transplantation in Multiple Myeloma